European Biotechnology feature: Biology as Software
bit.bio's CEO, envisions a new era of cell therapies, where cells themselves become intelligent drugs, precisely tailored to individual patients.
bit.bio's CEO, envisions a new era of cell therapies, where cells themselves become intelligent drugs, precisely tailored to individual patients.